Japan

Bayer lands regional rights to aficamten in Japan deal with Cytokinetics
First Word Pharma
Tue, 11/19/24 - 11:20 am
Bayer
Japan
Cytokinetics
aficamten
hypertrophic cardiomyopathy
Astellas unveils new Japan site for cell therapy research arm Universal Cells, transferring 12 roles overseas
Fierce Biotech
Wed, 10/9/24 - 09:07 pm
Astellas
Japan
cell therapy
Universal Cell
Aurion launches eye disease cell therapy in its first market
Pharmaphorum
Wed, 09/25/24 - 11:42 am
Aurion
Vyznova
bullous keratopathy
cell therapy
Japan
Eli Lilly's Alzheimer's drug approved in Japan
Reuters
Tue, 09/24/24 - 11:39 am
Eli Lilly
Japan
donanemab
Alzheimer's disease
Jazz’s cannabidiol therapy flunks in Japanese Phase III trial
Clinical Trials Arena
Fri, 08/23/24 - 10:47 am
Jazz Pharma
Cannabidiol
Japan
Epidiolex
Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development
PR Newswire
Tue, 08/6/24 - 11:19 am
Shinobi
Japan
grants
cell therapy
Pharmas form joint venture to jumpstart Japanese drug research
BioPharma Dive
Mon, 04/22/24 - 11:29 am
Japan
R&D
Takeda
Astellas
Sumitomo Mitsui Banking
AstraZeneca's phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan
Fierce Biotech
Fri, 02/2/24 - 11:53 am
AstraZeneca
Pfizer
acoramidis
Japan
clinical trials
cardiomyopathy
ATTR-CM
Eisai files biliary tract cancer drug tasurgratinib in Japan
Pharmaphorum
Mon, 12/18/23 - 10:14 am
Eisai
Japan
tasurgratinib
biliary tract cancer
Ascendis sells Japanese rights to Skytrofa and two other hormone drugs for $70M upfront
Fierce Biotech
Thu, 11/30/23 - 10:19 am
Ascendis
Japan
Skytrofa
growth hormone
Teijin Pharma
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Reuters
Thu, 11/16/23 - 10:22 pm
Japan
Daiichi Sankyo
COVID-19
vaccines
Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
Reuters
Tue, 09/26/23 - 10:23 am
Biogen
Eisai
Japan
Leqembi
Alzheimer's disease
SoftBank-backed Neumora Therapeutics aims to raise up to $264.8 mln in US IPO
NASDAQ
Tue, 09/12/23 - 10:44 am
Neumora Therapeuticsl
funding
Japan
SoftBank
IPOs
Daiichi Sankyo to close Japanese research and development subsidiary
Pharmaceutical Business Review
Tue, 08/8/23 - 10:17 am
Daiichi Sankyo
Japan
R&D
RD Novare
Aslan sells Japanese rights to would-be Dupixent rival for $12M
Fierce Biotech
Thu, 06/22/23 - 10:41 pm
Aslan
Dupixent
Japan
eczema
Sanofi
Regeneron
eblasakimab
With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A
Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan
Endpoints
Thu, 03/23/23 - 08:54 pm
Takeda
Japan
plasma therapy
drug manufacturing
Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand
Endpoints
Sun, 02/12/23 - 07:44 pm
Japan
Novavax
COVID-19
vaccines
Takeda
Daiichi Sankyo to build Japan's first mRNA vaccine manufacturing facility — report
Endpoints
Wed, 02/8/23 - 10:58 pm
Daiichi Sankyo
Japan
MRNA
vaccines
drug manufacturing
Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M
Fierce Pharma
Wed, 01/4/23 - 10:21 am
Moderna Therapeutics
M&A
DNA
Japan
OriCiro Genomics

Pages